Skip to main content
. Author manuscript; available in PMC: 2020 Sep 9.
Published in final edited form as: Mod Pathol. 2020 Apr 29;33(9):1822–1831. doi: 10.1038/s41379-020-0549-5

Table 6.

Multivariate Analysis of Entotic-CIC in PDAC and Patient

Factor P-value Hazard ratio (95% CI)
Entotic-CIC (present vs absent) 0.014 1.527 (1.090-2.138)
Gender (male vs female) 0.005 1.431 (1.115-1.836)
Location (primary vs metastasis) < 0.001 0.360 (0-0.474)
TP53 (mutated vs WT) 0.328 1.153 (0.866-1.535)
CDKN2A (mutated vs WT) 0.217 1.197 (0.900-1.592)
APC (mutated vs WT) 0.409 1.184 (0.792-1.771)
KRAS (amplified vs not amplified) 0.020 2.742 (1.173-6.408)
FGFR1 (amplified vs not amplified) 0.944 0.959 (0.295-3.119)
CDKN2A (deep deletion vs no deletion) 0.245 1.382 (0.801-2.386)